SUSAN DEVERS: Open Payments
NPI 1649598210 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,791 in 47 payments from 18 companies in 2025. Trend: 2023 $405 · 2024 $664 · 2025 $1,791
Food & beverage: $1,791
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $239 |
| HEARTFLOW, INC. | 4 | $191 |
| Merck Sharp & Dohme LLC | 7 | $174 |
| Kestra Medical Technology Services, Inc. | 1 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $135 |
| ABIOMED | 1 | $123 |
| Alnylam Pharmaceuticals Inc. | 1 | $119 |
| Regeneron Healthcare Solutions, Inc. | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $103 |
| PFIZER INC. | 5 | $96 |
Products named: FFRct, VERQUVO, Assure WCD, JARDIANCE, AMVUTTRA, EVKEEZA, Kerendia, Ozempic.
Industry payments across TX — which companies pay providers there.
